Schedule 13D ownership disclosure

CINCOR PHARMA INC

Security class unavailable · CUSIP: 17240Y109

Event date: 2022-08-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,073,949
Percent of class
14.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-093020
Form type
SC 13D/A
Filer
CinCor Pharma, Inc.
CIK
CIK 1868734
Filed
Aug 22, 2022
Reporting period
Aug 11, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub